UNICYCIVE THERAPEUTICS, INC. Multiemployer Plan, Employer Contribution, Cost
UNICYCIVE THERAPEUTICS, INC. (UNCY) reported Multiemployer Plan, Employer Contribution, Cost of $80.00 million for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-14.
Discontinued › Expense Statement › Operating Expenses
us-gaap:MultiemployerPlanEmployerContributionCost · last filed 2023-11-14
- UNICYCIVE THERAPEUTICS, INC. multiemployer plan, employer contribution, cost for the quarter ending 2023-09-30 was $29.00M, a 93.33% increase year-over-year.
- UNICYCIVE THERAPEUTICS, INC. multiemployer plan, employer contribution, cost for the quarter ending 2023-06-30 was $50.98M.
- UNICYCIVE THERAPEUTICS, INC. multiemployer plan, employer contribution, cost for the quarter ending 2023-03-31 was $21.00K.
- UNICYCIVE THERAPEUTICS, INC. multiemployer plan, employer contribution, cost for the quarter ending 2022-12-31 was -$50.94M.
| Period end | Multiemployer Plan, Employer Contribution, Cost 3 month | Multiemployer Plan, Employer Contribution, Cost 6 month | Multiemployer Plan, Employer Contribution, Cost 9 month | Multiemployer Plan, Employer Contribution, Cost 12 month |
|---|---|---|---|---|
| 2023-09-30 | $29.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $79.98M derived: sum of 2 quarters · filed 2023-11-14 | $80.00M 10-Q · filed 2023-11-14 | $29.06M derived: sum of 4 quarters · filed 2023-11-14 |
| 2023-06-30 | $50.98M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $51.00M 10-Q · filed 2023-08-14 | $60.00K derived: sum of 3 quarters · filed 2023-08-14 | $15.06M derived: sum of 4 quarters · filed 2023-11-14 |
| 2023-03-31 | $21.00K 10-Q · filed 2023-05-16 | -$50.92M derived: sum of 2 quarters · filed 2023-05-16 | -$35.92M derived: sum of 3 quarters · filed 2023-11-14 | |
| 2022-12-31 | -$50.94M derived: 10-Q 12 month − 10-Q 9 month · filed 2023-05-16 | -$35.94M derived: sum of 2 quarters · filed 2023-11-14 | $60.00K 10-Q · filed 2023-05-16 | |
| 2022-09-30 | $15.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $51.00M 10-Q · filed 2023-11-14 | ||
| 2022-06-30 | $36.00M 10-Q · filed 2023-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |